Projected Income Statement: Roche Holding AG

Forecast Balance Sheet: Roche Holding AG

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 1,882 18,167 15,584 18,699 17,337 12,186 6,986 1,085
Change - 865.3% -14.22% 19.99% -7.28% -29.71% -42.67% -84.47%
Announcement Date 04/02/21 03/02/22 02/02/23 01/02/24 30/01/25 - - -
1CHF in Million
Estimates

Cash Flow Forecast: Roche Holding AG

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 3,528 3,693 3,449 3,742 3,529 3,932 4,074 4,195
Change - 4.68% -6.61% 8.5% -5.69% 11.41% 3.63% 2.97%
Free Cash Flow (FCF) 1 10,943 15,691 13,041 11,288 15,336 15,006 16,172 16,852
Change - 43.39% -16.89% -13.44% 35.86% -2.15% 7.77% 4.2%
Announcement Date 04/02/21 03/02/22 02/02/23 01/02/24 30/01/25 - - -
1CHF in Million
Estimates

Forecast Financial Ratios: Roche Holding AG

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 41.63% 39.32% 39.53% 37.43% 38.91% 40.7% 40.52% 40.96%
EBIT Margin (%) 36.93% 34.87% 35.04% 32.77% 34.42% 35.49% 35.48% 36.14%
EBT Margin (%) 30.8% 27.7% 25.8% 23.98% 19.49% 30.62% 31.78% 33.03%
Net margin (%) 24.51% 22.18% 19.63% 19.58% 13.68% 21.74% 22.58% 23.66%
FCF margin (%) 18.76% 24.99% 20.61% 19.22% 25.35% 23.96% 24.86% 25.13%
FCF / Net Income (%) 76.55% 112.64% 104.99% 98.17% 185.28% 110.23% 110.08% 106.18%

Profitability

        
ROA 19.59% 19.09% 18.18% 16.71% 15.69% 13.61% 13.71% 13.49%
ROE 47.99% 56.02% 62.5% 45.73% 43.45% 43.89% 39.02% 35.57%

Financial Health

        
Leverage (Debt/EBITDA) 0.08x 0.74x 0.62x 0.85x 0.74x 0.48x 0.27x 0.04x
Debt / Free cash flow 0.17x 1.16x 1.2x 1.66x 1.13x 0.81x 0.43x 0.06x

Capital Intensity

        
CAPEX / Current Assets (%) 6.05% 5.88% 5.45% 6.37% 5.83% 6.28% 6.26% 6.26%
CAPEX / EBITDA (%) 14.53% 14.96% 13.79% 17.03% 14.99% 15.42% 15.46% 15.27%
CAPEX / FCF (%) 32.24% 23.54% 26.45% 33.15% 23.01% 26.2% 25.19% 24.9%

Items per share

        
Cash flow per share 1 21.46 24.39 22.79 20.02 25.05 24.03 25.79 26.73
Change - 13.64% -6.56% -12.16% 25.16% -4.08% 7.29% 3.67%
Dividend per Share 1 9.1 9.3 9.5 9.6 9.7 9.867 10.11 10.39
Change - 2.2% 2.15% 1.05% 1.04% 1.72% 2.45% 2.82%
Book Value Per Share 1 42.5 28.81 35.03 41.37 45.09 47.65 56.56 65.59
Change - -32.22% 21.58% 18.12% 8.98% 5.68% 18.7% 15.96%
EPS 1 16.52 16.2 15.37 14.31 10.31 18.14 19.61 21.08
Change - -1.94% -5.12% -6.9% -27.95% 75.98% 8.11% 7.5%
Nbr of stocks (in thousands) 854,642 800,952 800,579 798,652 796,789 795,401 795,401 795,401
Announcement Date 04/02/21 03/02/22 02/02/23 01/02/24 30/01/25 - - -
1CHF
Estimates
2025 *2026 *
P/E ratio 14.2x 13.1x
PBR 5.41x 4.56x
EV / Sales 3.46x 3.25x
Yield 3.83% 3.92%
More valuation ratios * Estimated data

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
255.00CHF
Average target price
301.38CHF
Spread / Average Target
+18.19%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ROG Stock
  4. Financials Roche Holding AG